Mutations in a vital class of regulatory molecules are an underappreciated cause of cancer because they impair the function of ‘G’ proteins, a versatile and vast family of signaling switches that underlie innumerable biological facets of life itself.
Five-year-old Dhana Rivas is fighting for her life on two fronts, fending off the acute lymphoblastic leukemia eating away at her frail body while her family simultaneously battles the shortage of cancer drugs plaguing Mexico.
Today, seven in 10 Americans are obese or overweight. The more overweight you are, the greater your risk for heart disease and cancers of the breast, colon and prostate. Maintaining a healthy weight is a major part of disease prevention.
So many minor inconveniences can now be solved via phone app, it makes sense that basic healthcare is on its way to becoming one of them. In the past few years, apps that purport to do things like manage diabetes, use period tracking data to warn users about PCOS, and identify potentially cancerous skin lesions have cropped up. But a new review published Monday in the BMJ raises serious concerns about that third category.
A new method to detect cancer in its early stages using a targeted MRI contrast agent that binds to proteins has been identified by a team of researchers led by Georgia State University Regents' Professor Jenny Yang.
A team of researchers led by the University of California San Diego has created a device that measures how ‘sticky’ cancer cells are, which could improve prognostic evaluation of patient tumors. The device is built with a microfluidic chamber that sorts cells by their physical ability to adhere to their environment.
Experts say cervical cancer could be eliminated in England through a combination of the vaccine and NHS screening, which will now test every woman for HPV, the virus that causes most cases of the disease.